Yaz is an oral contraceptive that can cause death, blood clots, premenstrual dysphoric disorder (PMDD) deep vein thrombosis, pulmonary embolism and strokes. FDA regulators issued Bayer a warning in October, 2008 that contained the FDA’s findings concerning Yaz, Yasmin and Ocella. According to the FDA, Bayer marketed Yaz and Yasmin for uses not approved by the FDA.
The most serious conditions including blood clots, stroke, and heart attack. These can be life-threatening or lead to permanent disability. The risk of blood clots is highest during the first year of use. This increased risk is highest when you first start taking birth control pills and when you restart the same or different birth control pills after not using them for a month or more. Users of drospirenone-containing pills (like YAZ) may have a higher risk of blood clots than users of birth control pills that do not contain drospirenone. The most common side effects were headache/migraine, menstrual irregularities, nausea/vomiting, breast pain/tenderness, fatigue, irritability, decreased libido, weight gain, and mood changes.